A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC).

[1]  N. Normanno,et al.  Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  A. Vahrmeijer,et al.  Three-dimensional quantitative margin assessment in patients with colorectal liver metastases treated with percutaneous thermal ablation using semi-automatic rigid MRI/CECT-CECT co-registration. , 2022, European journal of radiology.

[3]  J. Engstrand,et al.  Ablation versus resection for resectable colorectal liver metastases - Health care related cost and survival analyses from a quasi-randomised study. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  M. Gonen,et al.  Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis. , 2022, The Lancet. Oncology.

[5]  Ye Xu,et al.  Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study , 2022, European Radiology.

[6]  K. Wima,et al.  Microsatellite instability is associated with worse overall survival in resectable colorectal liver metastases. , 2022, American journal of surgery.

[7]  S. Weber,et al.  Volumetric analyses of ablation dimensions in microwave ablation for colorectal liver metastases , 2022, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[8]  R. Kianmanesh,et al.  Microwave Ablation for Colorectal Liver Metastases: A Systematic Review and Pooled Oncological Analyses , 2022, Cancers.

[9]  J. Fütterer,et al.  Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  D. Candinas,et al.  3D Quantitative Ablation Margins for Prediction of Ablation Site Recurrence After Stereotactic Image-Guided Microwave Ablation of Colorectal Liver Metastases: A Multicenter Study , 2021, Frontiers in Oncology.

[11]  B. Lissenberg-Witte,et al.  Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study , 2021, Cancers.

[12]  L. Held,et al.  Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study. , 2021, Cancer epidemiology.

[13]  R. Beets-Tan,et al.  Predicting local tumour progression after ablation for colorectal liver metastases: CT-based radiomics of the ablation zone. , 2021, European journal of radiology.

[14]  S. Weber,et al.  Volumetric Quantitative Ablation Margins for Assessment of Ablation Completeness in Thermal Ablation of Liver Tumors , 2021, Frontiers in Oncology.

[15]  Kai-yan Li,et al.  Long-term outcomes of ultrasound-guided percutaneous microwave ablation versus resection for colorectal cancer liver metastases: a propensity-score matched study , 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  S. Weber,et al.  Stereotactic and Robotic Minimally Invasive Thermal Ablation of Malignant Liver Tumors: A Systematic Review and Meta-Analysis , 2020, Frontiers in Oncology.

[17]  D. Candinas,et al.  Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival. , 2020, Surgery.

[18]  K. Ahrar,et al.  A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  J. Fütterer,et al.  Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group , 2020, Cancers.

[20]  S. Weber,et al.  Stereotactic Image-Guided Microwave Ablation for Malignant Liver Tumors—A Multivariable Accuracy and Efficacy Analysis , 2020, Frontiers in Oncology.

[21]  A. Schreyer,et al.  Improvement of the Primary Efficacy of Microwave Ablation of Malignant Liver Tumors by using a Robotic Navigation System , 2020, Radiology and oncology.

[22]  D. Hochhauser,et al.  Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT. , 2020, Health technology assessment.

[23]  E. Berber,et al.  Role of thermal ablation in the management of colorectal liver metastasis. , 2020, Hepatobiliary surgery and nutrition.

[24]  Si-Liang Chen,et al.  Resection vs. ablation for lesions characterized as resectable-ablative within the colorectal liver oligometastases criteria: a propensity score matching from retrospective study , 2020, PeerJ.

[25]  R. Troisi,et al.  Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  M. Bottai,et al.  Microwave ablation versus resection for colorectal cancer liver metastases - A propensity score analysis from a population-based nationwide registry. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  M. Oudkerk,et al.  Robotic versus Freehand Needle Positioning in CT-guided Ablation of Liver Tumors: A Randomized Controlled Trial. , 2019, Radiology.

[28]  G. Torzilli,et al.  Parenchymal sparing surgery brings treatment of colorectal liver metastases into the precision medicine era. , 2018, European journal of cancer.

[29]  M. Coolsen,et al.  Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial , 2018, BMC Cancer.

[30]  G. Toporek,et al.  Clinical application of high frequency jet ventilation in stereotactic liver ablations - a methodological study. , 2018, F1000Research.

[31]  E. Berber,et al.  A comparison of microwave thermosphere versus radiofrequency thermal ablation in the treatment of colorectal liver metastases. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[32]  D. Richel,et al.  Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis , 2018, CardioVascular and Interventional Radiology.

[33]  Michel Franken,et al.  System for CT‐guided needle placement in the thorax and abdomen: A design for clinical acceptability, applicability and usability , 2018, The international journal of medical robotics + computer assisted surgery : MRCAS.

[34]  J. Engstrand,et al.  Colorectal cancer liver metastases – a population-based study on incidence, management and survival , 2018, BMC Cancer.

[35]  J. Fütterer,et al.  Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[36]  M. Nichelatti,et al.  Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta‐Analysis , 2017, Clinical colorectal cancer.

[37]  C. V. van Kuijk,et al.  MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts , 2016, CardioVascular and Interventional Radiology.

[38]  J. Widder,et al.  Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases , 2016, The British journal of surgery.

[39]  W. Jarnagin,et al.  Long‐term outcomes following microwave ablation for liver malignancies , 2015, The British journal of surgery.

[40]  Muneeb Ahmed,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. , 2014, Journal of vascular and interventional radiology : JVIR.

[41]  D. Meier,et al.  Methods for constructing and assessing propensity scores. , 2014, Health services research.

[42]  J. Ledermann,et al.  Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. , 2014, European journal of cancer.

[43]  P. Austin.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments , 2013, Statistics in medicine.

[44]  H. Olsson,et al.  Population‐based data from the Swedish Colon Cancer Registry , 2013, The British journal of surgery.

[45]  E. J. van der Jagt,et al.  Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence , 2012, International journal of hepatology.

[46]  M. Choti,et al.  Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors , 2012, Clinical epidemiology.

[47]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[48]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.

[49]  P. Austin,et al.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies , 2010, Pharmaceutical statistics.

[50]  P. Austin.  American Journal of Epidemiology Practice of Epidemiology Statistical Criteria for Selecting the Optimal Number of Untreated Subjects Matched to Each Treated Subject When Using Many-to-one Matching on the Propensity Score , 2022 .

[51]  P. Austin,et al.  Assessing balance in measured baseline covariates when using many‐to‐one matching on the propensity‐score , 2008, Pharmacoepidemiology and drug safety.

[52]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[53]  P D Cleary,et al.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. , 2001, Journal of clinical epidemiology.